110 related articles for article (PubMed ID: 38303194)
1. [A Case of Rectal Cancer That Could Be Safely Resected by Laparoscopic Surgery, after Capecitabine plus L-OHP plus Cetuximab as Pre-Operative Chemotherapy].
Fukuda Y; Otsubo I; Miyazaki H; Kikuchi T; Kusano S; Mizuta N; Ashitani H; Tsunemi K; Toyokawa A
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1747-1749. PubMed ID: 38303194
[TBL] [Abstract][Full Text] [Related]
2. [A Case of Pathological Complete Response after Neoadjuvant Chemotherapy(S-1 plus Oxaliplatin)and Laparoscopic Low Anterior Resection for Rectal Cancer].
Ichinohe D; Morohashi H; Umetsu S; Yoshida T; Wakasa Y; Odagiri T; Kimura T; Suto A; Saito T; Yoshida E; Akasaka H; Jin H; Miura T; Sakamoto Y; Hakamada K
Gan To Kagaku Ryoho; 2016 Nov; 43(12):1715-1717. PubMed ID: 28133108
[TBL] [Abstract][Full Text] [Related]
3. [A Case of Conversion Surgery after Chemotherapy for Locally Advanced Unresectable Rectal Cancer].
Kawabe Y; Inoue A; Kagawa Y; Nishizawa Y; Ozato Y; Hayashi N; Shindo M; Suzuki K; Komatsu H; Hirota M; Miyazaki Y; Tomokuni A; Motoori M; Iwase K; Fujitani K
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1768-1770. PubMed ID: 38303201
[TBL] [Abstract][Full Text] [Related]
4. [Two Cases of Locally Advanced Lower Rectal Cancer with Pathological Complete Response after Cetuximab plus SOX as Neoadjuvant Chemotherapy].
Tokuhara K; Satake R; Ueyama Y; Yamamichi K; Sekimoto M
Gan To Kagaku Ryoho; 2021 Nov; 48(11):1405-1407. PubMed ID: 34795136
[TBL] [Abstract][Full Text] [Related]
5. Pre-operative chemoradiotherapy using capecitabine and cetuximab followed by definitive surgery in patients with operable rectal cancer.
Bazarbashi S; Omar A; Aljubran A; Alzahrani A; Alsanea N; Abduljabbar A; Alhomoud S; Ashari L; Balaraj K; Soudy H; Neimatallah M; Fagih M
Hematol Oncol Stem Cell Ther; 2016 Dec; 9(4):147-153. PubMed ID: 27613373
[TBL] [Abstract][Full Text] [Related]
6. Multicenter randomized phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab followed by total mesorectal excision in patients with high-risk rectal cancer (EXPERT-C).
Dewdney A; Cunningham D; Tabernero J; Capdevila J; Glimelius B; Cervantes A; Tait D; Brown G; Wotherspoon A; Gonzalez de Castro D; Chua YJ; Wong R; Barbachano Y; Oates J; Chau I
J Clin Oncol; 2012 May; 30(14):1620-7. PubMed ID: 22473163
[TBL] [Abstract][Full Text] [Related]
7. [A Case of Pathological CR in Local Advanced Rectal Cancer Treated with Laparoscopic ISR after XELOXIRI Chemotherapy].
Kawai K; Murata K; Hata T; Kagawa Y; Naito A; Sakamoto T; Murakami K; Katsura Y; Omura Y; Masuzawa T; Takeno A; Takeda Y
Gan To Kagaku Ryoho; 2019 Dec; 46(13):2096-2097. PubMed ID: 32157071
[TBL] [Abstract][Full Text] [Related]
8. [A Resected Case of Advanced Lower Rectal Cancer with Neoadjuvant Chemotherapy by FOLFOXIRI plus Cetuximab].
Yamada K; Ioka T; Suzuki N; Yoshida S; Tomochika S; Matsukuma S; Matsui H; Shindo Y; Tokumitsu Y; Watanabe Y; Iida M; Takeda S; Hazama S; Ueno T; Nagano H
Gan To Kagaku Ryoho; 2021 Dec; 48(13):2067-2069. PubMed ID: 35045495
[TBL] [Abstract][Full Text] [Related]
9. [A Case of Postoperative Recurrence of Rectal Cancer in Which Desensitization Therapy Was Effective against Oxaliplatin Allergy in L-OHP].
Katagiri M; Miwa K; Shimomura S; Yomoda T; Tajiri K; Nagasu S; Fujino S; Koushi K; Fujita F; Kinugasa T; Akagi Y
Gan To Kagaku Ryoho; 2018 May; 45(5):875-878. PubMed ID: 30026456
[TBL] [Abstract][Full Text] [Related]
10. [A Case of Advanced Rectal Cancer with Synchronous Pulmonary Metastasis Undergoing Laparoscopic Curative Resection after Chemotherapy].
Okano M; Okuyama M; Hata T; Ogino T; Kawada J; Kim Y; Tsujinaka T
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1376-1378. PubMed ID: 29394639
[TBL] [Abstract][Full Text] [Related]
11. Short-term outcomes of neoadjuvant chemotherapy with capecitabine plus oxaliplatin for patients with locally advanced rectal cancer followed by total or tumor-specific mesorectal excision with or without lateral pelvic lymph node dissection.
Sakamoto W; Kanke Y; Onozawa H; Okayama H; Endo H; Fujita S; Saito M; Saze Z; Momma T; Kono K
Fukushima J Med Sci; 2022 Aug; 68(2):89-95. PubMed ID: 35732415
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of capecitabine plus oxaliplatin (CapOX) as adjuvant chemotherapy for locally advanced rectal cancer (CORONA II).
Hattori N; Nakayama G; Uehara K; Aiba T; Ishigure K; Sakamoto E; Tojima Y; Kanda M; Kobayashi D; Tanaka C; Yamada S; Koike M; Fujiwara M; Nagino M; Kodera Y
Int J Clin Oncol; 2020 Jan; 25(1):118-125. PubMed ID: 31542847
[TBL] [Abstract][Full Text] [Related]
13. Effect of neoadjuvant cetuximab, capecitabine, and radiotherapy for locally advanced rectal cancer: results of a phase II study.
Sun PL; Li B; Ye QF
Int J Colorectal Dis; 2012 Oct; 27(10):1325-32. PubMed ID: 22430888
[TBL] [Abstract][Full Text] [Related]
14. [A Case of an Unresectable Locally Advanced Rectal Cancer with Surrounding Organ Invasion Successfully Resected after Chemotherapy with mFOLFOX6 plus Cetuximab].
Takagi H; Ariake K; Takemura S; Doi T
Gan To Kagaku Ryoho; 2016 Mar; 43(3):377-9. PubMed ID: 27067860
[TBL] [Abstract][Full Text] [Related]
15. Cetuximab in combination with capecitabine, irinotecan, and radiotherapy for patients with locally advanced rectal cancer: results of a Phase II MARGIT trial.
Horisberger K; Treschl A; Mai S; Barreto-Miranda M; Kienle P; Ströbel P; Erben P; Woernle C; Dinter D; Kähler G; Hochhaus A; Post S; Willeke F; Wenz F; Hofheinz RD;
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1487-93. PubMed ID: 19131187
[TBL] [Abstract][Full Text] [Related]
16. [A case of pathological complete response with neoadjuvant XELOX chemotherapy for locally advanced rectal cancer].
Kitahara T; Takemasa I; Inoue A; Osawa H; Miyo M; Mokutani Y; Ogawa H; Naito A; Hamabe A; Hiraki M; Munakata K; Uemura M; Nishimura J; Hata T; Mizushima T; Yamamoto H; Doki Y; Mori M
Gan To Kagaku Ryoho; 2014 Nov; 41(12):1569-71. PubMed ID: 25731255
[TBL] [Abstract][Full Text] [Related]
17. [A Case Report on a Successful Resection after FOLFIRI plus Cetuximab Therapy for Unresectable Colorectal Cancer with Multiple Liver Metastases].
Kanamori M; Kurumiya Y; Mizuno K; Sekoguchi E; Kobayashi S; Fukami Y; Kiriyama M; Aoyama H; Oiwa T; Miyamura K; Jinno T; Nakashima Y; Mori M
Gan To Kagaku Ryoho; 2017 May; 44(5):417-420. PubMed ID: 28536339
[TBL] [Abstract][Full Text] [Related]
18. Postoperative XELOX therapy for patients with curatively resected high-risk stage II and stage III rectal cancer without preoperative chemoradiation: a prospective, multicenter, open-label, single-arm phase II study.
Mizushima T; Ikeda M; Kato T; Ikeda A; Nishimura J; Hata T; Matsuda C; Satoh T; Mori M; Doki Y
BMC Cancer; 2019 Sep; 19(1):929. PubMed ID: 31533662
[TBL] [Abstract][Full Text] [Related]
19. Prospective phase II trial of neoadjuvant chemo-radiotherapy with Oxaliplatin and Capecitabine in locally advanced rectal cancer (XELOXART).
Ricardi U; Racca P; Franco P; Munoz F; Fanchini L; Rondi N; Dongiovanni V; Gabriele P; Cassoni P; Ciuffreda L; Morino M; Filippi AR; Aglietta M; Bertetto O
Med Oncol; 2013; 30(2):581. PubMed ID: 23606239
[TBL] [Abstract][Full Text] [Related]
20. Phase II trial of capecitabine and oxaliplatin (CAPOX) plus cetuximab in patients with metastatic colorectal cancer who progressed after oxaliplatin-based chemotherapy.
Souglakos J; Kalykaki A; Vamvakas L; Androulakis N; Kalbakis K; Agelaki S; Vardakis N; Tzardi M; Kotsakis AP; Gioulbasanis J; Tsetis D; Sfakiotaki G; Chatzidaki D; Mavroudis D; Georgoulias V
Ann Oncol; 2007 Feb; 18(2):305-10. PubMed ID: 17079693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
